Greenwich Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.48M | Buy |
16,154
+14
| +0.1% | +$7.35K | 0.41% | 33 |
|
|
2025
Q1 | $10.2M | Buy |
16,140
+59
| +0.4% | +$37.4K | 0.77% | 20 |
|
|
2024
Q4 | $11.5M | Buy |
16,081
+14
| +0.1% | +$9.97K | 0.81% | 19 |
|
|
2024
Q3 | $16.9M | Sell |
16,067
-12
| -0.1% | -$12.6K | 1.15% | 10 |
|
|
2024
Q2 | $16.9M | Sell |
16,079
-1
| -0% | -$1.05K | 1.23% | 10 |
|
|
2024
Q1 | $15.5M | Buy |
16,080
+5
| +0% | +$4.81K | 1.23% | 12 |
|
|
2023
Q4 | $14.1M | Sell |
16,075
-20
| -0.1% | -$17.6K | 1.39% | 11 |
|
|
2023
Q3 | $13.2M | Buy |
16,095
+24
| +0.1% | +$19.8K | 1.4% | 9 |
|
|
2023
Q2 | $11.5M | Sell |
16,071
-34
| -0.2% | -$24.4K | 1.21% | 12 |
|
|
2023
Q1 | $13.2M | Sell |
16,105
-7
| -0% | -$5.75K | 1.44% | 11 |
|
|
2022
Q4 | $11.6M | Sell |
16,112
-39
| -0.2% | -$28.1K | 1.28% | 13 |
|
|
2022
Q3 | $11.1M | Buy |
16,151
+12
| +0.1% | +$8.27K | 1.19% | 12 |
|
|
2022
Q2 | $9.54M | Sell |
16,139
-25
| -0.2% | -$14.8K | 1.26% | 13 |
|
|
2022
Q1 | $11.3M | Hold |
16,164
| – | – | 1.15% | 12 |
|
|
2021
Q4 | $10.2M | Sell |
16,164
-13
| -0.1% | -$8.21K | 0.83% | 13 |
|
|
2021
Q3 | $9.79M | Sell |
16,177
-61
| -0.4% | -$36.9K | 0.81% | 13 |
|
|
2021
Q2 | $9.07M | Buy |
16,238
+59
| +0.4% | +$33K | 0.77% | 15 |
|
|
2021
Q1 | $7.66M | Buy |
16,179
+50
| +0.3% | +$23.7K | 0.61% | 16 |
|
|
2020
Q4 | $7.79M | Buy |
16,129
+62
| +0.4% | +$30K | 0.68% | 16 |
|
|
2020
Q3 | $8.99M | Buy |
16,067
+2
| +0% | +$1.12K | 1.61% | 14 |
|
|
2020
Q2 | $10M | Sell |
16,065
-100
| -0.6% | -$62.4K | 1.92% | 13 |
|
|
2020
Q1 | $7.89M | Buy |
+16,165
| New | +$7.89M | 1.69% | 13 |
|